Inhibition of hypothalamic somatostatin release by beta-adrenergic antagonists.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Endocrinology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 1967576
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• GHRF causes biphasic stimulation of SRIF secretion from rat hypothalamic cells.

  1988cited by this paper
• Evidence that diminished pituitary responsivity to GHRF is secondary to intracellular GH pool depletion.

  1988cited by this paper
• Growth hormone (GH)-releasing factor stimulates hypothalamic somatostatin release: an inhibitory feedback effect on GH secretion.

  1986cited by this paper
• Stimulation by alpha-adrenergic mechanisms of the secretion of growth hormone-releasing factor (GRF) from perifused rat hypothalamus.

  1986cited by this paper
• Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophysial-portal circulation of the rat.

  1985cited by this paper
• Augmentation by propranolol of growth hormone-releasing hormone-(1-44)-NH2-induced growth hormone release in normal short and normal children.

  1985cited by this paper
• The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion.

  1984cited by this paper
• Somatostatin release from dispersed hypothalamic cells - effects of membrane depolarization, calcium and glucose deprivation.

  1983cited by this paper
• Somatocrinin (growth hormone releasing factor) in vitro bioactivity; Ca++ involvement, cAMP mediated action and additivity of effect with PGE2.

  1982cited by this paper
• Hypothalamic hypophysiotropic hormones and neurotransmitter regulation: current views.

  1981cited by this paper
• Evidence for a growth hormone releasing factor mediating alpha-adrenergic influence on growth hormone secretion in the rat.

  1981cited by this paper
• Release of somatostatin and thyrotropin-releasing hormone from rat hypothalamic fragments in vitro.

  1980cited by this paper
• Dopamine and norepinephrine stimulate somatostatin release by median eminence fragments in vitro.

  1978cited by this paper
• Neuropharmacological regulation of episodic growth hormone and prolactin secretion in the rat.

  1978cited by this paper
• Stimulation of immunoreactive somatostatin release from hypothalamic synaptosomes by high (K+) and dopamine.

  1977cited by this paper
• Stimulation of growth hormone secretion by levodopa-propranolol in children and adolescents.

  1975cited by this paper
• The effect of adrenergic receptor blockade on the exercise-induced serum growth hormone rise in normals and juvenile diabetics.

  1971cited by this paper
• Adrenergic receptor control mechanism for growth hormone secretion.

  1968cited by this paper

• Central and peripheral regulation of the GH/IGF-1 axis: GHRH and beyond

  2024cites this paper
• Somatostatin system: molecular mechanisms regulating anterior pituitary hormones.

  2014cites this paper
• New syndrome of paraganglioma and somatostatinoma associated with polycythemia.

  2013cites this paper
• Acute hyperglycemia and activation of the beta-adrenergic system do not exhibit synergistic inhibitory actions on thyrotropin-releasing hormone (TRH)-induced thyroid stimulating hormone (TSH) secretion.

  2005influential citation
• Acute hyperglycemia and activation of the beta-adrenergic system exhibit synergistic inhibitory actions on growth hormone (GH) releasing hormone-induced GH release.

  2003cites this paper
• Growth Hormone: A Promising Treatment for the Failing Heart?

  2000cites this paper
• Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.

  1998cites this paper
• Effects of beta-adrenergic agonists and antagonists on the growth hormone response to growth hormone-releasing hormone in anorexia nervosa.

  1998cites this paper
• Influence of beta-adrenergic agonists and antagonists on the GH-releasing effect of Hexarelin in man

  1996cites this paper
• Combined pyridostigmine-thyrotrophin-releasing hormone test for the evaluation of hypothalamic somatostatinergic activity in healthy normal men.

  1995cites this paper
• Effect of two β2-agonist drugs, salbutamol and broxaterol, on the growth hormone response to exercise in adult patients with asthmatic bronchitis

  1995cites this paper
• Clonidine potentiates the growth hormone response to a growth hormone releasing hormone challenge in hypothalamic growth hormone releasing hormone deficient rats.

  1995cites this paper
• Low circulating IGF‐I levels in hyperthyroidism are associated with decreased GH response to GH‐releasing hormone

  1995cites this paper
• Interaction of salbutamol and galanin on both basal and growth hormone releasing hormone-stimulated growth hormone secretion in humans

  1995cites this paper
• Interaction of salbutamol with pyridostigmine and arginine on both basal and GHRH‐stimulated GH secretion in humans

  1994cites this paper
• Glucagon stimulates GH secretion after intramuscular but not intravenous administration. Evidence against the assumption that glucagon per se has a GH-releasing activity

  1994cites this paper
• Therapeutical doses of salbutamol inhibit the somatotropic responsiveness to growth hormone-releasing hormone in asthmatic children

  1993cites this paper
• Studies on alpha 2-adrenergic modulation of hypothalamic somatostatin secretion in rats.

  1993cites this paper
• Interactions between the effects of opioid, serotonin and alpha-2-adrenergic receptor agonists on growth hormone release in the male rat. Intrahypothalamic administration.

  1993cites this paper
• Inhibition by Salbutamol of GHRH-Induced GH Release in Type 1 Diabetes Mellitus

  1992cites this paper
• Serum thyrotropin response to combined arginine and thyrotropin-releasing hormone administration provides evidence for an altered somatostatinergic tone in acromegaly.

  1992cites this paper
• Somatostatin and growth hormone-releasing factor release from Zucker rat hypothalamic tissue.

  1992cites this paper
• Anticonvulsants inhibit rat neuronal somatostatin release.

  1992cites this paper
• Arginine reinstates the somatotrope responsiveness to intermittent growth hormone-releasing hormone administration in normal adults.

  1991cites this paper